FR11C0023I1 - - Google Patents

Info

Publication number
FR11C0023I1
FR11C0023I1 FR11C0023C FR11C0023I1 FR 11C0023 I1 FR11C0023 I1 FR 11C0023I1 FR 11C0023 C FR11C0023 C FR 11C0023C FR 11C0023 I1 FR11C0023 I1 FR 11C0023I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR11C0023I1 publication Critical patent/FR11C0023I1/fr
Application granted granted Critical
Publication of FR11C0023I2 publication Critical patent/FR11C0023I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR11C0023C 1996-06-04 2011-07-08 Derives de benzimidazole a activite antihistaminique Active FR11C0023I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (2)

Publication Number Publication Date
FR11C0023I1 true FR11C0023I1 (fr) 2011-08-19
FR11C0023I2 FR11C0023I2 (fr) 2012-03-16

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0023C Active FR11C0023I2 (fr) 1996-06-04 2011-07-08 Derives de benzimidazole a activite antihistaminique

Country Status (27)

Country Link
US (1) US5877187A (fr)
EP (1) EP0818454B1 (fr)
JP (1) JP4218991B2 (fr)
CN (1) CN1105716C (fr)
AR (1) AR008386A1 (fr)
AT (1) ATE264317T1 (fr)
AU (1) AU725700B2 (fr)
BR (1) BR9703276A (fr)
CA (1) CA2206754C (fr)
CZ (1) CZ289278B6 (fr)
DE (2) DE122011000006I1 (fr)
DK (1) DK0818454T3 (fr)
ES (1) ES2124167B1 (fr)
FR (1) FR11C0023I2 (fr)
HR (1) HRP970307B1 (fr)
HU (1) HU227598B1 (fr)
IN (1) IN186319B (fr)
LU (1) LU91798I2 (fr)
MX (1) MXPA97004127A (fr)
NO (2) NO313195B1 (fr)
PL (1) PL188908B1 (fr)
PT (1) PT818454E (fr)
RU (1) RU2182150C2 (fr)
SI (1) SI0818454T1 (fr)
TR (1) TR199700464A2 (fr)
TW (1) TW438794B (fr)
ZA (1) ZA974893B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102470A3 (en) 1998-07-01 2002-05-28 Takeda Chemical Industries Ltd 1,3-azole derivatives as retinoid-associated receptor regulators and their use
ES2216625T3 (es) 1998-11-27 2004-10-16 ABBOTT GMBH & CO. KG Bencimidazoles substituidos y su empleo como inhibidores de parp.
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
CN1290843C (zh) * 2002-04-19 2006-12-20 费斯制药股份有限公司 4－[2－[4－[1－(2－乙氧基乙基)－1H－苯并咪唑－2－基]－1－哌啶基]乙基]－α,α－二甲基苯乙酸的多晶型物
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US8367704B2 (en) 2008-02-12 2013-02-05 Yuhan Corporation Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compounds
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
MX366869B (es) * 2013-03-15 2019-07-29 Hercules Inc Composición y método para producir composiciones para el cuidado personal con propiedades de deposición mejoradas.
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
WO2014188453A2 (fr) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Nouveau procédé de préparation de l'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl) phényl]-2-méthylpropanoïque
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (fr) 2014-12-29 2016-07-06 Faes Farma, S.A. Nouveaux dérivés de benzimidazole en tant qu'agents antihistaminiques
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
WO2017017301A1 (fr) * 2015-07-24 2017-02-02 Urquima, S.A Formes cristallines de la bilastine et procédés pour leur préparation
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170817A1 (fr) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-cristaux de composés de benzimidazole
EP3170816A1 (fr) 2015-11-20 2017-05-24 Faes Farma, S.A. Compositions sursaturées de composés de benzimidazole
WO2017167949A1 (fr) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Formes cristallines de bilastine
WO2017191651A1 (fr) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Formes à l'état solide d'acide 2-[4-(2-{4-[1-(2-éthoxyéthyl)-1h-benzimidazol-2-yl]-1-pipéridinyl}éthyl)phényl]-2-méthylpropanoïque et procédé de préparation associé
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
EP3453384B1 (fr) 2017-09-07 2020-05-27 Alfred E. Tiefenbacher (GmbH & Co. KG) Comprime pharmaceutique comprenant du bilastine
US11642309B2 (en) 2017-10-16 2023-05-09 Faes Farma, S.A. Aqueous compositions comprising bilastine and mometasone
EP3470062B1 (fr) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Composition de comprimé pharmaceutique comprenant de la bilastine polymorphe forme 3 et de l'aluminométasilicate de magnésium
WO2019097091A1 (fr) 2017-12-18 2019-05-23 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Composition de comprimé pharmaceutique comprenant une forme de bilastine 3 et une charge soluble dans l'eau
WO2019141563A1 (fr) 2018-01-18 2019-07-25 Faes Farma, S.A. Compositions ophtalmiques comprenant de la bilastine, une bêta-cyclodextrine et au moins un agent gélifiant
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (fr) 2019-04-16 2020-10-21 Faes Farma, S.A. Compositions pharmaceutiques stables et préservées de bilastine
CR20230109A (es) 2020-07-30 2023-05-11 Faes Farma Sa Sistema de liberación de fármacos descongestivos y bilastina
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
WO2022106923A1 (fr) 2020-11-18 2022-05-27 BioPharma Synergies, S. L. Composition de poudre orodispersible comprenant un composé antihistaminique
WO2022135863A1 (fr) 2020-12-23 2022-06-30 Biohorm, S.L. Composition non micronisée de bilastine
WO2023156559A1 (fr) 2022-02-17 2023-08-24 Faes Farma, S.A. Composition de bilastine pour administration parentérale une fois par jour

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2284740T3 (es) * 1992-08-03 2007-11-16 Sepracor Inc. Carboxilato de terfenadina y el tratamiento de la irritacion cutanea.
EP2261207A1 (fr) * 1993-06-25 2010-12-15 Aventisub II Inc. Composés intermédiaires pour la préparation de dérivés antihistaminiques de pipéridine de 4-diphénylméthyl/diphénylméthoxy

Also Published As

Publication number Publication date
ES2124167B1 (es) 1999-09-16
TR199700464A3 (tr) 1997-12-21
PL320358A1 (en) 1997-12-08
CZ172397A3 (en) 1997-12-17
NO2011008I2 (no) 2012-05-14
NO313195B1 (no) 2002-08-26
EP0818454B1 (fr) 2004-04-14
TW438794B (en) 2001-06-07
AU2467297A (en) 1997-12-11
HRP970307A2 (en) 1998-04-30
CA2206754C (fr) 2007-01-23
TR199700464A2 (xx) 1997-12-21
JP4218991B2 (ja) 2009-02-04
MXPA97004127A (es) 2005-07-25
DE122011000006I1 (de) 2011-06-16
DE69728608T2 (de) 2005-04-21
ES2124167A1 (es) 1999-01-16
PT818454E (pt) 2004-08-31
AU725700B2 (en) 2000-10-19
IN186319B (fr) 2001-08-04
AR008386A1 (es) 2000-01-19
NO972525L (no) 1997-12-05
ZA974893B (en) 1997-12-30
BR9703276A (pt) 2004-08-17
SI0818454T1 (en) 2004-08-31
LU91798I2 (fr) 2011-05-23
ATE264317T1 (de) 2004-04-15
JPH1059961A (ja) 1998-03-03
EP0818454A1 (fr) 1998-01-14
CN1176964A (zh) 1998-03-25
CZ289278B6 (cs) 2001-12-12
CA2206754A1 (fr) 1997-12-04
HRP970307B1 (en) 2002-02-28
DE69728608D1 (de) 2004-05-19
HU9700997D0 (en) 1997-07-28
CN1105716C (zh) 2003-04-16
HU227598B1 (en) 2011-09-28
US5877187A (en) 1999-03-02
DK0818454T3 (da) 2004-07-12
RU2182150C2 (ru) 2002-05-10
FR11C0023I2 (fr) 2012-03-16
NO2011008I1 (no) 2011-06-06
NO972525D0 (no) 1997-06-03
HUP9700997A1 (hu) 1999-09-28
PL188908B1 (pl) 2005-05-31

Similar Documents

Publication Publication Date Title
FR11C0023I1 (fr)
AR026659A2 (fr)
BRPI9713914B8 (fr)
IN190939B (fr)
ITCH960003A0 (fr)
ITAQ960003A0 (fr)
ITMI960525A0 (fr)
ITMI960471V0 (fr)
BR9603859A (fr)
BR7601346U (fr)
ECSDI960326S (fr)
IN183499B (fr)
ITMC960039V0 (fr)
ITMC960035A0 (fr)
IN185662B (fr)
ITMI960635V0 (fr)
BR7600721U (fr)
IN189267B (fr)
IN191275B (fr)
IN191753B (fr)
ITGE960020V0 (fr)
CN3040805S (fr)
CN3045208S (fr)
CN3047495S (fr)
CN3042289S (fr)